Cargando…
Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
Accumulating evidence suggests that neuroinflammation is involved in bipolar disorder (BD) pathogenesis. The tumor necrosis factor-alpha (TNF-α) antagonist infliximab was recently reported to improve depressive symptoms in a subpopulation of individuals with BD and history of childhood maltreatment....
Autores principales: | Mansur, Rodrigo B., Delgado-Peraza, Francheska, Subramaniapillai, Mehala, Lee, Yena, Iacobucci, Michelle, Rodrigues, Nelson, Rosenblat, Joshua D., Brietzke, Elisa, Cosgrove, Victoria E., Kramer, Nicole E., Suppes, Trisha, Raison, Charles L., Chawla, Sahil, Nogueras-Ortiz, Carlos, McIntyre, Roger S., Kapogiannis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226726/ https://www.ncbi.nlm.nih.gov/pubmed/32268604 http://dx.doi.org/10.3390/cells9040895 |
Ejemplares similares
-
Peripheral inflammatory biomarkers define biotypes of bipolar depression
por: Lee, Yena, et al.
Publicado: (2021) -
Changes in the gut microbiome associated with infliximab in patients with bipolar disorder
por: Bharwani, Aadil, et al.
Publicado: (2021) -
Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis
por: Lee, Yena, et al.
Publicado: (2022) -
Changes in insulin resistance following antidepressant treatment
mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022) -
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)